10x Genomics, Inc. - Common Stock (NQ:TXG)

93.50 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Q2 Earnings Highs And Lows: 10x Genomics (NASDAQ:TXG) Vs The Rest Of The Life Sciences Tools & Services Stocks

August 24, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

Bio-Techne, 10x Genomics, Lumen, EPAM, and ASGN Shares Are Soaring, What You Need To Know

August 22, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested...

Via StockStory

Topics Economy

LGI Homes, Moderna, Fortrea, 10x Genomics, and Cogent Shares Are Falling, What You Need To Know

August 21, 2025

A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S....

Via StockStory

Topics Economy Stocks

Analyst Expectations For 10x Genomics's Future ↗

August 08, 2025

Via Benzinga

1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down

August 20, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Topics Bonds

1 Volatile Stock to Own for Decades and 2 That Underwhelm

August 14, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Artificial Intelligence Economy

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

What's Driving the Market Sentiment Around 10x Genomics? ↗

June 05, 2025

Via Benzinga

Forecasting The Future: 7 Analyst Projections For 10x Genomics ↗

June 04, 2025

Via Benzinga

Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know

August 12, 2025

A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index...

Via StockStory

Topics Bonds Economy Stocks

TXG Q2 Deep Dive: Robust Product Demand and Cautious Outlook Amid Funding Uncertainty

August 11, 2025

Biotech company 10x Genomics (NASDAQ:TXG) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 12.9% year on year to $172.9 million. On the other hand, next quarter’s...

Via StockStory

Why 10x Genomics (TXG) Stock Is Falling Today

August 08, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 5.5% in the morning session after the company reported strong second-quarter results that surpassed Wall Street's expectations for both revenue...

Via StockStory

Topics Earnings

10x Genomics (NASDAQ:TXG) Reports Upbeat Q2, Stock Soars

August 08, 2025

Biotech company 10x Genomics (NASDAQ:TXG) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 12.9% year on year to $172.9 million. On the other hand, next quarter’s revenue guidance of...

Via StockStory

10X Genomics Inc-Class A (NASDAQ:TXG) Surprises with Strong Q2 2025 Earnings and Revenue Beat ↗

August 07, 2025

10X Genomics (TXG) reported strong Q2 2025 earnings, beating revenue and EPS estimates, sparking a 4.68% after-hours stock surge. Revenue hit $172.91M, up 22.8%, with EPS at $0.28 vs. expected loss....

Via Chartmill

Earnings To Watch: 10x Genomics (TXG) Reports Q2 Results Tomorrow

August 05, 2025

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Economy World Trade

PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know

July 29, 2025

A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending...

Via StockStory

Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know

July 23, 2025

A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally.

Via StockStory

Topics Stocks World Trade

3 Unprofitable Stocks We’re Skeptical Of

July 23, 2025

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

Via StockStory

Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know

July 18, 2025

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...

Via StockStory

Topics Lawsuit World Trade

3 Russell 2000 Stocks with Red Flags

July 15, 2025

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know

July 11, 2025

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.

Via StockStory

Topics ETFs Stocks World Trade

Demystifying 10x Genomics: Insights From 8 Analyst Reviews ↗

June 24, 2025

Via Benzinga

Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)

June 23, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at life sciences tools & services stocks,...

Via StockStory

Topics Artificial Intelligence

Delta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To Know

June 16, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%) as reports pointed to easing tensions between Israel and Iran.

Via StockStory

Topics Economy Government Stocks

1 Cash-Producing Stock with Exciting Potential and 2 to Ignore

June 16, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Be Wary Of

June 12, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

Topics Artificial Intelligence

TXG Q1 Earnings Call: Academic Funding Uncertainty Drives Guidance Withdrawal and Cost Reductions

June 10, 2025

Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.8% year on year to $154.9 million. On the other hand, next quarter’s...

Via StockStory

Topics Intellectual Property

Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration ↗

May 30, 2025

Ark Invest made significant trades in TSLA, TXG, NTLA, DDD, and ADPT. Purchase of TXG and NTLA from ARKG and ARKK funds, and sale of TSLA, DDD, and ADPT from various funds.

Via Benzinga

Topics Government

Powell, Mayville Engineering, Graham Corporation, Hyster-Yale Materials Handling, and 10x Genomics Shares Skyrocket, What You Need To Know

May 27, 2025

A number of stocks jumped in the morning session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting...

Via StockStory

Topics Government Stocks World Trade

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.